Umeclidinium + Vilanterol Trifenatate
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Umeclidinium
umeclidinium - Vilanterol Trifenatate
vilanterol-trifenatate
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| umeclidinium bromide and vilanterol trifenatateUS | 0.0625 mg / 0.025 mg | GlaxoSmithKline LLC |
| Anoro Ellipta 55/22 mcg inhalation PowderSG TW |
| GLAXOSMITHKLINE PTE LTD |
| Umeclidinium and Vilanterol ElliptaUS |
| Prasco Laboratories |
| vilanterol trifenatate + umeclidinium bromideAU | — | — |
| 安肺樂易利達 55/22 mcg 乾粉吸入劑TW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| 肺樂喜易利達92/55/22 mcg乾粉吸入劑TW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| Trelegy Ellipta 92/55/22 mcg Inhalation PowderTW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| 肺樂喜易利達184/55/22 mcg 乾粉吸入劑TW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| Trelegy Ellipta 184/55/22 mcg Inhalation PowderTW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| ANORO ELLIPTA 62.5/25 umeclidinium (as bromide)/vilanterol (as trifenatate) 62.5 microgram/25 microgram powder for inhalationAU |
| GlaxoSmithKline Australia Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.